NCT03852940

Brief Summary

To demonstrate that a strategy involving early first-line enteral nutrition is associated with improved preservation of gut mucosa integrity, as assessed based on the plasma citrulline level at H72, compared to a strategy involving early first-line parenteral nutrition

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
169

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 27, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2015

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2017

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
Last Updated

February 25, 2019

Status Verified

July 1, 2017

Enrollment Period

5 months

First QC Date

July 18, 2017

Last Update Submit

February 22, 2019

Conditions

Keywords

vasoactive drugmechanical ventilationearly enteral nutritionintensive care unitearly parenteral nutritioncritical care medicinenosocomial infectionmortalityshock

Outcome Measures

Primary Outcomes (1)

  • Plasma citrulline level

    72 hours

Secondary Outcomes (10)

  • SOFA score

    first week

  • plasma levels of citrulline

    Day 0, Day 3, Day 8

  • I-FABP

    Day 0, Day 3, Day 8

  • proportion of patients whose plasma I-FABP is ≥100 pg/mL

    Day 0, Day 3, Day 8

  • proportion of patients whose plasma citrulline is ≤10 μL/L

    Day 0, Day 3, Day 8

  • +5 more secondary outcomes

Study Arms (2)

Parenteral nutrition

OTHER

Patients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.

Other: Parenteral nutrition

Enteral nutrition

OTHER

Patients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.

Other: Enteral Nutrition

Interventions

Also known as: Intravenous nutrition, intravenous feeding
Parenteral nutrition
Also known as: Enteral feeding
Enteral nutrition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Invasive mechanical ventilation expected to be required more than 48 hours
  • Nutrition started within 24 hours after initiation of endotracheal mechanical ventilation
  • Treatment with vasoactive drug administered via a central venous catheter
  • Age over 18 years
  • Signed information

You may not qualify if:

  • History of esophageal, gastric, duodenal or pancreatic surgery
  • Bleeding from the esophagus, stomach or bowel
  • enteral nutrition via gastrostomy or jejunostomy
  • pregnancy
  • Treatment-limitation decisions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

CHU Amiens

Amiens, 80054, France

Location

Centre hospitalier d'Annecy

Annecy, 74374, France

Location

CH de Dieppe

Dieppe, 76202, France

Location

CHU Lille

Lille, 59000, France

Location

CHU Saint Louis

Paris, 75010, France

Location

CHU Tours

Tours, 37044, France

Location

MeSH Terms

Conditions

ShockHyperphagiaCross Infection

Interventions

Parenteral NutritionEnteral Nutrition

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveSigns and SymptomsInfectionsIatrogenic DiseaseDisease Attributes

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Jean REIGNIER, MD, PhD

    CHD Vendee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2017

First Posted

February 25, 2019

Study Start

January 27, 2015

Primary Completion

July 7, 2015

Study Completion

July 1, 2017

Last Updated

February 25, 2019

Record last verified: 2017-07

Locations